Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/29/2009 First Published: 3/7/2008


1.		Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-30610 CALGB 30610, RTOG 0538, NCT00632853

Last Modified: 1/24/2009 First Published: 3/22/2007


2.		Phase I/II Study of Sunitinib Malate, Cisplatin, and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				CALGB-30504 CALGB 30504, NCT00453154

First Published: 8/20/2007


3.		Phase I/II Study of Obatoclax Mesylate and Topotecan Hydrochloride in Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				MSKCC-07082 07-082, 7937, NCT00521144

Last Modified: 5/22/2008 First Published: 5/4/2007


4.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Last Modified: 7/27/2008 First Published: 8/20/2007


5.		Phase II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation (Abraxane) and Carboplatin in Patients With Extensive-Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				UNC-LCCC-0519 LCCC 0519, NCT00454324

Last Modified: 1/27/2009 First Published: 11/1/2007


6.		Phase II Study of Filgrastim (G-CSF) and Pegfilgrastim in Patients Undergoing Radiotherapy and Chemotherapy Comprising Cisplatin and Etoposide Followed by Adjuvant Cisplatin and Etoposide for Limited Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0623 RTOG 0623, NCT00554463

Last Modified: 6/10/2008 First Published: 2/15/2008


7.		Phase II Randomized Study of Standard First-Line Chemotherapy Comprising Carboplatin and Etoposide Followed by Observation Versus Autologous Dendritic Cell-Adenovirus p53 Vaccine With Versus Without Tretinoin in Patients With Extensive Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				MCC-15206 MCC-IRB-9792, MCC 15206, INTROGEN-RAC-0705-857, NCT00618891

First Published: 7/30/2008


8.		Phase II Study of Sorafenib Tosylate in Combination With Cisplatin and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CASE-8507 CASE8507, CASE-8507-CC486, NCT00726986

Last Modified: 11/20/2008 First Published: 10/14/2008


9.		Phase II Study of R-(-)-gossypol in Patients With Recurrent Extensive Stage Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				MAYO-MC0721 MC0721, 8027, NCT00773955

First Published: 1/21/2009


10.		Phase II Randomized Study of Topotecan Hydrochloride With Versus Without Aflibercept in Patients With Extensive Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 and over				NCI				SWOG-S0802 S0802, NCT00828139

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute